Canadian Investment Regulatory Organization Trade Resumption - CZZL

Canadian Investment Regulatory Organization Trade Resumption - CZZL

Trading resumes in:

Company: Cizzle Brands Corporation

Cboe CA Exchange Symbol: CZZL

All Issues: Yes

Resumption (ET): 9:00 AM

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Canadian Investment Regulatory Organization (CIRO) – Halts/Resumptions

News Provided by PR Newswire via QuoteMedia

CZZL:AQL
The Conversation (0)
Cizzle Brands Corporation (CBOE:CZZL)

Cizzle Brands Corporation

A Sports Nutrition Company Leading the Next Wave in Health and Wellness

A Sports Nutrition Company Leading the Next Wave in Health and Wellness Keep Reading...
Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications

Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications

Inaugural Episode Features CEO Rich Christopher on DehydraTECH Platform, GLP-1 Market Opportunity and Commercial Strategy KELOWNA, BC / ACCESS Newswire / May 1, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug delivery platforms, today... Keep Reading...
Lexaria Bioscience (NASDAQ:LEXX)

Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended

Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or the "Company"), a global innovator in oral drug delivery platforms, provides this update on the Material Transfer Agreement ("MTA") originally entered into on August 30, 2024 with a pharmaceutical company ("PharmaCO") to evaluate Lexaria's... Keep Reading...
Hand places a blue block labeled "M&A" atop a pyramid of wooden blocks with business icons.

Fit to Work: GLP-1 and Metabolic Health in the M&A Sector

Biotechnology, pharmaceutical and medtech companies each contributed about 30 percent of deal volume to overall mergers and acquisitions (M&A) activity in 2025.The surge is attributed to rising obesity and diabetes cases, with the 2025 World Obesity Atlas projecting that the total number of... Keep Reading...
Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs

Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs

Contracts signed for Animal Study #2: GLP-1-A26-2Amycretin and retatrutide to be tested for compatibility with DehydraTECH KELOWNA, BC / ACCESS Newswire / April 23, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX), (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is... Keep Reading...
Biotech therapy capsule containing DNA strand surrounded by cells.

Top 3 Canadian Biotech Stocks in 2026

Biotech is a dynamic industry that is driving scientific advances and innovation in healthcare. In Canada, the biotech sector is home to companies pursuing cutting-edge therapies and medical technologies.Here the Investing News Network profiles the three best-performing Canadian biotech stocks... Keep Reading...

Interactive Chart

Latest Press Releases

Related News